KCAS Bio will be attending the 74th Conference on Mass Spectrometry and Allied Topics (ASMS) in San Diego, California from May 31 – June 4, 2026. This event is a cornerstone in the field of mass spectrometry, bringing together experts, innovators, and visionaries to share advancements and explore the future of analytical technologies.
Mass Spectrometry at the Forefront of Scientific Innovation
The ASMS Conference serves as a hub for groundbreaking research and technological progress in mass spectrometry and allied disciplines. With a comprehensive program that spans diverse applications in pharmaceuticals, biotechnology, and life sciences, the event is a premier platform for discussing innovations in analytical methodologies, instrumentation, and data analysis.
KCAS Bio’s Commitment to Advancing Analytical Excellence
At KCAS Bio, mass spectrometry is central to our mission of delivering precise, reliable, and impactful bioanalytical solutions. Our expertise in hybrid LC-MS/MS assays, biomarker quantification, and pharmacokinetics ensures that we meet the evolving needs of drug development programs. We are committed to leveraging cutting-edge mass spectrometry technologies to accelerate our clients’ success in bringing transformative therapies to patients.
Connect with KCAS Bio at ASMS 2026
We invite you to join us at ASMS 2025 in San Diego to learn more about our mass spectrometry capabilities and explore how we can support your projects. Reach out to schedule a meeting with our team at the event. Together, let’s push the boundaries of mass spectrometry and advance the science that drives innovative drug development.